Denali Therapeutics, Inc. (DNLI)
19.03
+0.92
(+5.08%)
USD |
NASDAQ |
May 20, 12:43
Denali Therapeutics Shareholders Equity (Quarterly) : 926.10M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Biogen, Inc. | 18.65B |
| Neurocrine Biosciences, Inc. | 3.407B |
| Arcturus Therapeutics Holdings, Inc. | 191.36M |
| Agenus, Inc. | -221.22M |
| Curis, Inc. | 12.71M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.266B |
| Total Liabilities (Quarterly) | 339.92M |
| Debt to Equity Ratio | 0.0432 |
| Current Ratio | 9.285 |
| Net Debt Paydown Yield | 0.09% |